Resource data sheet
DNA Bank Top
Please review the QC test results indicated by check icon below as well as clone information before placing your order.

pGL4-phCYP1A1 (#RDB07541)

Promoter collection, Human CYP1A1 promoter

Alternative name U2842-3
Clone info. PCR amplified human CYP1A1 promoter sequence was inserted into a firefly luciferase vector. Cloned fragment: 74726956 to 74725495(NC_000015.10); relatively -1428 to +34, where +1 corresponds to 1 nt of NM_000499.5.
Comment PCR cloning, forward primer: GGATGGCGCGTAACGATGT; reverse primer: GGATCAGGGAAGGTTCCAAGG.
Vector backbone pGL4.10 [Luc2] (Plasmid)
Selectable markers Amp^r
Gene/insert name Human cytochrome P450, family 1, subfamily A, polypeptide 1 genomic DNA
Depositor|Developer DNA Bank, |
 
Remarks, protocol and/or map (pdf) RDB07541.pdf

Distribution information

Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms
Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ]
MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ]
Please visit Information of Request for Distribution.[link] 
Terms and conditions for distribution In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested.
Additional terms and conditions:
The use of the BIOLOGICAL RESOURCE is restricted to the academic researches conducted by non-profit organization. By using this material, the RECIPIENT agrees to be bound by the conditions of the limited use statement of the Promega Corporation.
提供案内 (日本国内) [open/close]

必要書類
提供依頼書  [依頼書の記入例 ]
提供同意書 (MTA, 非営利学術目的用)[Word] [MTAの記入例 ]
手続きの概要は、「提供申込みについて[link]」をご覧ください。
MTAに書く使用条件 謝辞の表明を必要とする。
MTAに書く付加的使用条件:
本件リソースの使用は学術機関での学術研究に限る。本件リソースの使用にあたって、利用者はプロメガ社の限定使用条件に従う必要がある。

Catalog # Resource name Shipping form Fee (non-profit org.)
RDB07541 pGL4-phCYP1A1 DNA solution

Please review the QC test results indicated by check icon below as well as clone information before placing your order.

How to cite this biological resource

Materials & Methods section:

The pGL4-phCYP1A1 was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB07541).

Reference section:

Further references such as user reports and related articles (go to bottom)


QC test results

RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by check icon as well as clone information before placing your order.

Test sheet RDB15081_A7Etp1.pdf check

Nucleotide sequence of a portion of this resource (if available).

Primer: pGL4-4174F
Sequence file: RDB15081_A7Eta.seq check
>RDB07541_15081_A7Et_pGL4-4174F_F02_17_ABI24.ab1
    1 ATAGGGCAGA CATTTCTCTG GCCTAACTGG CCGGTACCTG AGCTCGCTAG CCTCGAGGAT
   61 GGATGGCGCG TAACGATGTT AGCTGGGGCC AGGTTGAGCT AGGCACGCAA ATACAACTTT
  121 TTTTTTCCTG GAAACCCTGT AACAGGAAGG TTCCGGAGGG CGGGACAGCG TCGGAGGCAG
  181 GCAGCTAGGC CATGCCAAAT GGCACTGGGG CTTCGTGTCG TGCCACAGGC GTGGACCGAA
  241 AATGCGGACA CATGCAGGCT GCCTCTCCTC GCAGGCAGAA GCCACACGCA GACCTAGACC
  301 CTTTGCACCG CATCCCCTTA TTCAATCGCG CACCCGCCAC CCTTCGACAG TTCCTCTCCC
  361 TCCACCCCAA CCCCACGCCG CGCGCGAGGC TGGCCCTTTA AGAGCCCCGC CCCGACTCCC
  421 TCCCCCCTCG CGTGACTGCG AGCCCCCGCG CCGGGCCGGG GAATGGGTCG GCTGGGTGGC
  481 TGCGCGGGCC TCCGGTCCTT CTCACGCAAC GCCTGGGCAC CGCGCCTCCG GGCCAGGTGG
  541 GGCGGGGACG GGCCGCCTGA CCTCTGCCCC CTAGAGGGAT GTCGCCGGCG CACGCAAGCT
  601 AGCCGGGGGT AGGGTGGGGG CTCCGCGCCA GGTGCCCCCT CCGTGGTCCC TGGGCCCGAG
  661 TCTTTCCGTG GCCCCCCGCC GCCGGATTTC TGTGCTCTGC CAATCAAAGC ACTAGCCACC
  721 CCGGGAGCCA AGAGGGACCC TCAAGGGCCG GTGGGTCCTG GCTGGAGGGA CCGCGCGTTG
  781 CAATCAGCAC TAAGGCGATC CTAGAGGCTG CGAGGAGCCG CTAGTGAGCG CTCAGCGAGC
  841 CTGCCCCTTC GCCATCCATT CCGATCCTTC AATCAAGAGG CGCGAACCTC AGCTAGTCGC
  901 CCGGGCTCTG GGGGACAGGT CCAGCCCCGC GGCGCCTCTG GCCTTCCGGC CCCCGTGACC
  961 TCAGGGCTGG GGTCGCAGCG CTTCTCACGC GAGCCGGGAC TCAGTAACCC CGGGAAGGAG
 1021 GTCACCACGG GGCAGCCCCG CCCCCGCCTG CCGAGTCCTC TAGCTGTAGC GCTGGGGAGC
 1081 CATCTGCACG CTCAAGCGAT CAGTTGGGTT GCAAAATGAC GAAGAGAGTC CCGCGCCCAG
1141 CATGAGCATC CCGTTAAC
//
Primer: pGL4-136R
Sequence file: RDB15081_A7Etb.seq check
>RDB07541_15081_A7Et_pGL4-136R_G02_20_ABI24.ab1
    1 GGTTGAGTTT TGGCATCTTC CATGGTGGCT TTACCAACAG TACCGGATTG CCAAGCTTGG
   61 CCGCCGAGGC CAGATCTTGA TGGATCAGGG AAGGTTCCAA GGAACTGTCA CCTTCAGGGT
  121 GAGGGTGAAG GCACTGCCAC CTTTATAGGC GGGCTTGTAC GTGTGGCCAC GCCTCCTTCC
  181 CTGGAGCGAG CTGAGATGGA GGGAGAAGCA GCCTGAACCG GGCTGGTCTC TCTGGGATTG
  241 GAGAGAAAGG TGGCGGAGGG CGGCGGGGGT GGGGGGTCGG GTGGGCAAGA ACCCACTATG
  301 GGACACATCT CGGTGCCTGT ACATAGAGGG GTGAGGGCTG GGAACACCTG GAAGTCCCAA
  361 TTCCAAGGCG TCCCAAGGGC AGTGCAGAAC CCAGCCGAGG AGGGGGCTTG AGGGAGAAGT
  421 CCCAGGACAG CCCGAAGAGA GGGTACGGGA AGCTCCATCC TGGGGCGCGG GGACTCCTCT
  481 TCGTCATTTT TGCACCCACT GGAACGCTGG GCGTGCAGAT GCCTCCCCAG CGCTACAGCC
  541 TACCAGGACT CGGCAGGCGG GGGCGGGGCT GCCCCGTGGT GACCTCCTTC CCGGGGTTAC
  601 TGAGTCCCGG CTCGCGTGAG AAGCGCTGCG ACCCCAGCCC TGAGGTCACG GGGGCCGGAA
  661 GGCCAGAGGC GCCGCGGGGC TGGACCTGTC CCCCAGAGCC CGGGCGACTA GCTGAGGTTC
  721 GCGCCTCTTG ATTGAAGGAT CGGAATGGAT GGCGAAGGGG CAGGCTCGCT GAGCGCTCAC
  781 TAGCGGCTCC TCGCAGCCTC TAGGATCGCC TTAGTGCTGA TTGCAACGCG CGGTCCCTCC
  841 AGCCAGGACC CACCGGCCCT TGAGGGTCCC TCTTGGCTCC CGGGGTGGCT AGTGCTTTGA
  901 TTGGCAGAGC ACAGAAATCC GGCGGCGGGG GGGCCACGGA AAGACTCGGG CCCAGGGACC
  961 ACGGAGGGGG GCACCTGGCG CGGAGCCCCC ACCCTACCCC CCGGCTAGCT TTGCGTGCGC
 1021 CCGGCGACAT CCCTCTAGGG GCAGAGTCAG CGGCCCGTCC CCCGCCCCAC TGACCGGGAG
 1081 GCGCGATGCC AGGCCGATGC GTGAGAGGAC CGAGGCCCCG CGCCAGCCAC CCCAGGCTCG
1141 GAA
//
Primer: pAxCALNL_F1
Sequence file: RDB15081_A7Etc.seq check
>RDB07541_15081_A7Et_pAxCALNL_F1_H02_23_ABI24.ab1
    1 ACAAGTGTAT CTTATCATGT CTGCTCGAAG CGGCCGGCCG CCCCGACTCT AGAATTATTA
   61 CACGGCGATC TTGCCGCCCT TCTTGGCCTT AATGAGAATC TCGCGGATCT TGCGGGCGTC
  121 CAACTTGCCG GTCAGTCCTT TAGGCACCTC GTCCACGAAC ACAACACCAC CGCGCAGCTT
  181 CTTGGCGGTT GTAACCTGGC TGGCCACATA GTCCACGATC TCCTTCTCGG TCATGGTTTT
  241 ACCGTGTTCC AGCACGACGA CTGCGGCGGG CAGCTCGCCG GCATCGTCGT CGGGCAGGCC
  301 GGCGACCCCG GCGTCGAAGA TGTTGGGGTG TTGCAGCAGG ATGCTCTCCA GTTCGGCTGG
  361 GGCTACCTGG TAGCCCTTGT ATTTGATCAG GCTCTTCAGC CGGTCCACGA TGAAGAAGTG
  421 CTCGTCCTCG TCCCAGTAGG CGATGTCGCC GCTGTGCAGC CAGCCGTCCT TGTCGATGAG
  481 AGCGTTTGTA GCCTCGGGGT TGTTAACGTA GCCGCTCATG ATCATGGGGC CACGGACGCA
  541 CAGCTCGCCG CGCTGGTTCA CACCCAGTGT CTTACCGGTG TCCAAGTCCA CCACCTTAGC
  601 CTCGAAGAAG GGCACCACCT TGCCTACTGC GCCAGGCTTG TCGTCCCCTT CGGGGGTGAT
  661 CAGAATGGCG CTGGTTGTTT CTGTCAGGCC GTAGCCCTGG CGGATGCCTG GTAGGTGGAA
  721 GCGTTTGGCC ACGGCCTCAC CTACCTCCTT GCTGAGCGGC GCCCCGCCGC TGGCGATCTC
  781 GTGCAAGTTG CTTAGGTCGT ACTTGTCGAT GAGAGTGCTC TTAGCGAAGA AGCTAAATAG
  841 TGTGGGCACC AGCAGGGCAG ATTGAATCTT ATAGTCTTGC AAGCTGCGCA AGAATAGCTC
  901 CTCCTCGAAG CGGTACATGA GCACGACCCG AAAGCCGCAG ATCAAGTAGC CCAGCGTGGG
  961 TGAACATGCC GAAGCCGTGG TGAAATGGCA CCACGCTGAG GATAGCGGTG TCGGGGATGA
 1021 TCTGGGTTGC CGAAGATGGG GTCGCGGGCA TGACTGAATC GGACACAGCG ATGCGGTGCG
1081 GTAGGCTACG CCTGGCCATT CAGTACTGCC ACTACTGATC ATGATCAGGA CCGAATG
//

Please visit Sequencing and PCR primers for primer information.


References

Original, user report and related articles